Login to Your Account



Targovax shares surge on vaccine survival data in pancreatic cancer

By Cormac Sheridan
Staff Writer

Thursday, February 2, 2017

DUBLIN – Shares in Targovax ASA surged almost 40 percent to an all-time high Thursday on preliminary top-line data for its peptide-based therapeutic vaccine TG01.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription